Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-57P (RNA, U6 small nuclear 57, pseudogene) is a *non-coding RNA pseudogene* in the human genome, related to the canonical U6 small nuclear RNA (snRNA), which is a critical component of the spliceosome machinery required for nuclear intron splicing[1][2][3]. As a pseudogene, RNU6-57P is a non-functional, likely non-expressed genomic sequence that does not encode any proteins or functional RNAs, in contrast with its parent, functional U6 snRNA. Pseudogenes of the U6 family are considered genomic relics and have no known biological or disease relevance, nor direct regulatory or therapeutic value[4]. Note: Information about “RNU6-57P” specifically is extremely sparse in the literature. All available evidence and conventions indicate that as a pseudogene, it should not be treated as a canonical target or functional entity. If you are seeking information about the canonical functional U6 snRNA, that would be “RNA, U6 small nuclear” (often abbreviated as U6, such as RNU6-1), not the “pseudogene” version[1][2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 57, pseudogene (RNU6-57P).